Showing results (61-70 of 1,250) with videos related to
Sort By:
Pageof 125
Expert Review of Molecular Diagnostics|April 11, 2022
Perspective: cell death mechanisms and early diagnosis as precondition for disease modification in Parkinson's disease: are we on the right track?Thomas MüllerNeuropsychiatric Disease and Treatment|March 21, 2009
Rivastigmine in the treatment of patients with Alzheimer's diseaseThomas MüllerExpert Review of Neurotherapeutics|September 23, 2009
Role of intraspinal steroid application in patients with multiple sclerosisThomas MüllerNeurodegenerative Disease Management|July 11, 2020
Safinamide in the treatment of Parkinson's diseaseThomas MüllerCurrent Opinion in Investigational Drugs (London, England : 2000)|January 17, 2003
CPI-1189. CentaurThomas MüllerExpert Opinion on Pharmacotherapy|April 6, 2002
Drug treatment of non-motor symptoms in Parkinson's diseaseThomas MüllerNeurology and Therapy|July 18, 2025
Update on the Present and Future Pharmacologic Treatment of Parkinson's DiseaseThomas MüllerClinical Neuropharmacology|May 16, 2013
Pharmacokinetic considerations for the use of levodopa in the treatment of Parkinson disease: focus on levodopa/carbidopa/entacapone for treatment of levodopa-associated motor complicationsThomas MüllerExpert Opinion on Drug Metabolism & Toxicology|September 9, 2014
Pharmacokinetic/pharmacodynamic evaluation of rasagiline mesylate for Parkinson's diseaseThomas MüllerPageof 125